cardiovascular benefits of glp-1 agonists Frontiers GLP-1 Agonists in Cardiovascular Diseases:

Best results are achieved alongside a healthy diet and consistent exercise

Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management

Obesity management: Used widely for weight loss, even in non-diabetic individuals

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

A summary of the guidelines for perioperative management of GLP-1 RAs, GIP agonists, & SGLT2 inhibitors in adults.